Anti-CyclinB2 [X29.2]
Invented by Julian Gannon from The Francis Crick Institute
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
- Datasheet
- References (4)
- Inventor Info
Info
| Catalogue Number | 151182 |
| Applications | FACS IHC IF IP WB |
| Antigen/Gene or Protein Targets | Cyclin B2 |
| Synonyms | Cyclin B2; HsT17299 |
| Reactivity | Mammalian and Xenopus laevis |
| Relevance | Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). |
| Host | Mouse |
| Immunogen | Xenopus laevis cyclin B2 |
| Positive Control | Xenopus laevis testis |
| Subclass | IgG1 |
| Myeloma Used | Sp2/0-Ag14 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Strain | Balb/c |
| Notes | Antibody X29.2 cross reacts with B1 |
| Research Area | Cell Cycle, Epigenetics & Nuclear Signalling |
References: 4 entries
Gisselsson et al. 2008. PLoS One. 3(4):e1871. PMID: 18392149.
When the genome plays dice: circumvention of the spindle assembly checkpoint and near-random chromosome segregation in multipolar cancer cell mitoses.
Europe PMC ID: 18392149
Potapova et al. 2006. Nature. 440(7086):954-8. PMID: 16612388.
The reversibility of mitotic exit in vertebrate cells.
Europe PMC ID: 16612388
Add a reference
References: 4 entries
Gisselsson et al. 2008. PLoS One. 3(4):e1871. PMID: 18392149.
When the genome plays dice: circumvention of the spindle assembly checkpoint and near-random chromosome segregation in multipolar cancer cell mitoses.
Potapova et al. 2006. Nature. 440(7086):954-8. PMID: 16612388.
The reversibility of mitotic exit in vertebrate cells.
Add a reference
